Paper16633338
VEGF receptor signalling - in control of vascular function.
Olsson AK and 3 others. Nat Rev Mol Cell Biol, 2006. Cited by 2,573 papers, by iCite.
Cite this record
ConductScience Library. VEGF receptor signalling - in control of vascular function. Papers, record 16633338. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16633338
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neovascularization, Physiologic | Major topic |
| Receptors, Vascular Endothelial Growth Factor | Major topic |
| Signal Transduction | Major topic |
| Animals | |
| Embryonic Development | |
| Humans | |
| Stem Cells | |
| Vascular Endothelial Growth Factors |
Source PubMed
Trials3
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT03219398 | The Effect of Lower Intraabdominal Pressure on Syndecan-1, sVEGF-R2, Occludin, KIM-1, and IL-6 on Living Donor Laparoscopic Nephrectomy | Background | ClinicalTrials.gov | |
| NCT03883412 | Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007) | Background | ClinicalTrials.gov | |
| NCT04575844 | Effects of Exercise and GLP-1 Agonism on Muscle Microvascular Perfusion and Insulin Action in Adults With Metabolic Syndrome | Background | ClinicalTrials.gov |
Cited by1,458
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,573 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42942141 | VEGF Signaling and Targeted Therapies in Cancer: Molecular Mechanisms, Clinical Applications, Resistance, and Cardiorenal Toxicities. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42942141 | PubMed |
| 42903656 | Graphene oxide-induced multiple iPSC spheroid formation for enhanced production of angiogenic exosomes accelerating tissue regeneration. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42903656 | PubMed |
| 42889244 | Targeting vascular endothelial growth factor (VEGF)-induced angiogenesis with Rosa hybrida leaf extract via VEGF receptor-2 signaling and matrix metalloproteinase-2 inhibition. | Nutr Res Pract | 2026 | https://conductscience.org/library/papers/42889244 | PubMed |
| 42836994 | VEGF pathway signalling across pulmonary neuroendocrine tumours: associations with histological subtypes in a multicentre study. | Virchows Arch | 2026 | https://conductscience.org/library/papers/42836994 | PubMed |
| 42829897 | VEGF165b attenuates LPS-induced acute lung injury via antagonizing the VEGF165a/VEGFR2 signaling pathway. | Angiogenesis | 2026 | https://conductscience.org/library/papers/42829897 | PubMed |
| 42796425 | Polydeoxyribonucleotide Enhances Liver Regeneration Following Partial Hepatectomy in Rats in Association with Growth Factor and A2A Receptor Signaling. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/42796425 | PubMed |
| 42764959 | Deconvoluting the multi-faceted roles of alternative splicing events in cancer: From underlying mechanisms to innovative therapeutics. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42764959 | PubMed |
| 42762961 | Receptor tyrosine kinase signaling in mammalian eye development. | Dev Biol | 2026 | https://conductscience.org/library/papers/42762961 | PubMed |
| 42751636 | Five VEGFA Polymorphisms and Bleeding During Warfarin Therapy in a Saudi Population: An Exploratory Retrospective Cohort Study. | Pharmgenomics Pers Med | 2026 | https://conductscience.org/library/papers/42751636 | PubMed |
| 42747637 | Homocysteine and mitophagy in diabetic retinopathy: unraveling the underlying molecular crosstalk. | Endocrine | 2026 | https://conductscience.org/library/papers/42747637 | PubMed |
| 42737738 | Research Progress on Angiogenesis and Involution Mechanisms of Infantile Hemangioma and Its Regulation by Active Components of Salvia miltiorrhiza. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42737738 | PubMed |
| 42726186 | Remote periosteal distraction promotes ischemic diabetic foot wound repair associated with VEGF/VEGFR2-related angiogenic responses. | J Mol Histol | 2026 | https://conductscience.org/library/papers/42726186 | PubMed |
| 42717534 | Structural Basis of Lymphangiogenic Receptor VEGFR-3 Activation Mediated by Distinctive Clustering of the Ligand-Receptor Complex. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42717534 | PubMed |
| 42652176 | Glycation at the Gate: A Brain Endothelial Glycocalyx Model and Therapeutic Roadmap for Alzheimer's Disease. | Biomedicines | 2026 | https://conductscience.org/library/papers/42652176 | PubMed |
| 42592693 | Discovery of VEGFR-2 Inhibitors From Leonurus japonicus via Integrated Genetic Authentication, Molecular Networking, and In Silico Analysis. | Arch Pharm (Weinheim) | 2026 | https://conductscience.org/library/papers/42592693 | PubMed |
| 42584757 | Succinic Acid-Sunitinib Combination Treatment Downregulates the Angiogenic Gene Expressions in Sunitinib- Resistant Renal Cancer Cell Line. | Cell Biochem Biophys | 2026 | https://conductscience.org/library/papers/42584757 | PubMed |
| 42571573 | Engineering functional vasculatures to reconstruct sympathetic-parasympathetic circuits for bladder function after spinal cord injury. | Bioact Mater | 2027 | https://conductscience.org/library/papers/42571573 | PubMed |
| 42538573 | CEUS with VEGFR2-targeted microbubbles for monitoring of early immunotherapy effects in a colorectal cancer model. | Cancer Imaging | 2026 | https://conductscience.org/library/papers/42538573 | PubMed |
| 42510843 | Transcriptomic Signatures of Exercise-Modality Responses in Aged Human Skeletal Muscle. | Genes (Basel) | 2026 | https://conductscience.org/library/papers/42510843 | PubMed |
| 42509338 | CLK3 regulates tumor angiogenesis by modulating HIF1α ubiquitination. | Cancer Gene Ther | 2026 | https://conductscience.org/library/papers/42509338 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FLT1 | 2321 | PubTator's text mining | https://conductscience.org/library/genes/2321 | NCBI Gene |
| FLT4 | 2324 | PubTator's text mining | https://conductscience.org/library/genes/2324 | NCBI Gene |
| KDR | 3791 | PubTator's text mining | https://conductscience.org/library/genes/3791 | NCBI Gene |
| NRP1 | 8829 | PubTator's text mining | https://conductscience.org/library/genes/8829 | NCBI Gene |
| PGF | 5228 | PubTator's text mining | https://conductscience.org/library/genes/5228 | NCBI Gene |
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 | NCBI Gene |
| VEGFB | 7423 | PubTator's text mining | https://conductscience.org/library/genes/7423 | NCBI Gene |
| VEGFC | 7424 | PubTator's text mining | https://conductscience.org/library/genes/7424 | NCBI Gene |
| VEGFD | 2277 | PubTator's text mining | https://conductscience.org/library/genes/2277 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16633338
GET https://conductscience.org/api/papers/v1/16633338/cited_by?page=2